Publication: Comparison of methotrexate and Azathioprine as the first steroid-sparing immunosuppressive agent in patients with Takayasu's Arteritis
Program
KU-Authors
KU Authors
Co-Authors
Kaymaz-Tahra, Sema
Tsechelidis, Ozun Bayindir
Ince, Burak
Isik, Ozlem Ozdemir
Kutu, Muhammet Emin
Karakas, Ozlem
Yildirim, Tuba Demirci
Ademoglu, Zeliha
Ediboglu, Elif Durak
Uludogan, Burcu Ceren Ekti
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
Type
Embargo Status
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Background Conventional disease-modifying anti-rheumatic drugs (cDMARDs) are recommended in addition to glucocorticoids (GC) for all active Takayasu's arteritis (TAK) patients as the first-line therapy.However, there is limited data comparing cDMARDs as the first-line immunosuppressive (IS) treatment. Objectives In this study, we aimed to compare the outcomes of methotrexate (MTX) and azathioprine (AZA), which were used most frequently as the first-line cDMARDs in TAK patients.
Source
Publisher
Elsevier
Subject
Rheumatology, Medicine
Citation
Has Part
Source
Arthritis and Rheumatology
Book Series Title
Edition
DOI
10.1136/annrheumdis-2023-eular.6172